Functional assays for cholesterol absorption inhibitors

Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality

Compounds and therapies for the prevention of vascular and non-vascular pathologies

Elastin prevents occlusion of body vessels by vascular smooth muscle cells

Disease markers for early stage atherosclerosis

Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Autophilic antibodies

Methods and compositions for using alveolar macrophage phospholipase A2

Method of assessing the risk of atherosclerosis

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Diagnostic method for atherosclerosis

Multiparameter method of screening for atherosclerosis-related coronary heart disease or stroke

Novel integrin ligand ITGL-TSP

Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide

Control of gene induced by oxidated lipids in human artery wall cells

Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor

Methods for diagnosis of cardiovascular disease

Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

Adiponectin-associated protein

Compounds and therapies for the prevention of vascular and non-vascular pathologies

Use of remnant lipoprotein in the treatment and prevention of cardiovascular disease